Abb Ltd
F:ABJA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abb Ltd
F:ABJA
|
CH |
|
U
|
USANA Health Sciences Inc
SWB:USJ
|
US |
|
Camtek Ltd
F:CMZ
|
IL |
|
T
|
TOC Co Ltd
XMUN:T3O
|
JP |
|
U
|
USANA Health Sciences Inc
F:USJ
|
US |
|
P
|
Petroleo Brasileiro SA Petrobras
XMUN:PJXC
|
BR |
Wall St Price Targets
ABJA Price Targets Summary
Abb Ltd
According to Wall Street analysts, the average 1-year price target for ABJA is 83.35 EUR with a low forecast of 58.58 EUR and a high forecast of 101.56 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABJA's stock price target?
Price Target
83.35
EUR
According to Wall Street analysts, the average 1-year price target for ABJA is 83.35 EUR with a low forecast of 58.58 EUR and a high forecast of 101.56 EUR.
What is the Revenue forecast for Abb Ltd?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Abb Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 5 years is 11%.
What is the Operating Income forecast for Abb Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 5 years is 12%.
What is the Pre-Tax Income forecast for Abb Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Abb Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 5 years is 11%.
